Assessment Of Safety Of UK-390,957
NCT00219609
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
1058
Enrollment
INDUSTRY
Sponsor class
Conditions
Ejaculation
Interventions
DRUG:
UK-390,957
Sponsor
Pfizer